Hologic (HOLX) Proxy Filing summary

Executive summary

• Definitive proxy statement filed regarding proposed acquisition by Blackstone Inc. and TPG Capital, with transaction details and timeline outlined.

• Employees and shareholders to receive $76 per share in cash plus a contingent value right (CVR) of up to $3 per share, contingent on Breast Health business revenue goals in FY26 and FY27.

• Forward-looking statements highlight potential risks, including regulatory approvals, shareholder approval, and business disruptions.

Voting matters and shareholder proposals

• Shareholders are urged to read the proxy statement and related materials for information on the proposed transaction and to participate in the proxy voting process.

Board of directors and corporate governance

• Information on directors and executive officers, including their interests in the merger and security ownership, is disclosed in the proxy statement and related SEC filings.